Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-018675

Chief Executive Officer sold 123,615 shares at an average $55.03 ($6,803,044)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2024-02-27 Sale 10b5-1 −62,810 $55.00 $3,454,550 3,043,619 D: show line 1 in the form
Santos da Silva Jorge Chief Executive Officer 2024-02-28 Sale 10b5-1 −56,065 $55.00 $3,083,575 2,987,554 D: show line 2 in the form
Santos da Silva Jorge Chief Executive Officer 2024-02-29 Sale 10b5-1 −4,740 $55.89 $264,919 2,982,814 D: show line 3 in the form
Open-market sales · 123,615 sh · avg $55.03 · $6,803,044
Loading xslF345X05/ownership.xml…